Symposium

Come join Drs. Jean Elwing, Steven Nathan, and Ioana Preston at this exciting breakfast symposium on Monday, October 7, 2024 to gain knowledge on the latest treatments in PH-ILD! Pulmonary hypertension among patients with interstitial lung diseases (PH-ILD) is currently under-recognized and is associated with increased morbidity, mortality, and healthcare burden. Individualized treatment approaches need to be incorporated in the continuum of care to improve early detection, accurate diagnosis, and improved patient outcomes. In this live symposium, expert faculty will inform and guide on recent insights to screen for, detect, and accurately diagnose PH-ILD. The presentation will use didactic, case-based, and conversational formats to provide practical guidance and increase familiarity with the latest best-practice approaches for treatment and management of PH-ILD, to ultimately improve the quality of life of patients.

Please contact Lashley Russ for more information: lruss@practicepointcme.com 813-925-7149

FACULTY

Steven Nathan, MD

Medical Director, Advanced Lung Disease
and Transplant Program
Inova Fairfax Hospital

Jean Elwing, MD

Professor of Medicine
Director, Pulmonary Hypertension Program
University of Cincinnati

Ioana Preston, MD

Associate Professor of Medicine
Tufts University School of Medicine
Director, Pulmonary Hypertension Center
Pulmonary, Critical Care and Sleep Division
Tufts Medical Center

This activity is provided in collaboration with Rush University Medical Center and Practice Point Communications.

Supported by an independent educational grant from United Therapeutics, a public benefit company

Practice Point Communications and Rush University Medical Center do not share your name or contact information with any other party.

This symposium is not supported, endorsed, or accredited by the American College of Chest Physicians.